BioCorRx Inc.
BICX
$0.2866
-$0.2034-41.51%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -29.65% | 43.67% | |||
| Depreciation & Amortization | 94.03% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -32.23% | 20.85% | |||
| Operating Income | 32.23% | -21.20% | |||
| Income Before Tax | 18.86% | -22.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.86% | -22.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 146.09% | 53.29% | |||
| Net Income | 21.70% | -22.19% | |||
| EBIT | 32.23% | -21.20% | |||
| EBITDA | 32.75% | -21.31% | |||
| EPS Basic | 32.84% | -5.98% | |||
| Normalized Basic EPS | 30.92% | 3.13% | |||
| EPS Diluted | 32.84% | -4.92% | |||
| Normalized Diluted EPS | 30.92% | 3.13% | |||
| Average Basic Shares Outstanding | 16.60% | 15.32% | |||
| Average Diluted Shares Outstanding | 16.60% | 15.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||